M. Peter Hecht's most recent trade in Cyclerion Therapeutics Inc was a trade of 351,037 Common Stock done . Disclosure was reported to the exchange on July 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Ten Percent Owner | 16 Jul 2026 | 351,037 | 910,240 (3%) | 1% | - | Common Stock | ||
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Ten Percent Owner | 16 Jul 2026 | 351,037 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 2.75 per share. | 25 Mar 2025 | 181,818 | 559,203 (2%) | 0% | 2.8 | 500,000 | Common Stock |
| Cyclerion Therapeutics Inc | Hecht Peter M. | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 15,000 | 377,385 (1%) | 0% | 0 | Common Stock | |
| Cyclerion Therapeutics Inc | M. Peter Hecht | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 20,000 | 347,385 (1%) | 0% | 0 | Common Stock | |
| Cyclerion Therapeutics Inc | M. Peter Hecht | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 15,000 | 362,385 (1%) | 0% | 0 | Common Stock | |
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 351,037 | 351,037 | - | - | Series A Convertible Preferred Stock | |
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 8.68 per share. | 19 May 2023 | 225,000 | 327,385 (1%) | 0% | 8.7 | 1,953,000 | Common Stock |
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 430,000 | 430,000 | - | - | Employee Stock Option (Right to Buy) | |
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 52,950 | 52,950 | - | - | Employee Stock Option (Right to Buy) |